je.st
news
Tag: license
Oman to license third operator
2016-02-15 01:00:00| Total Telecom industry news
Omanetel, Ooredoo set to face new competition as TRA is instructed to start licensing process.
Western Springs Police Reports: Fraud, DUI, Suspended License
2016-02-07 17:39:50| Footwear - Topix.net
Someone fraudulently obtained and used a victim's credit card number to make several unauthorized retail purchases between Dec. 9, 2015, and Jan. 12. The purchases totaled $607.30 and were made in Ohio and New York. Kenneth M. Chin, 25 of the 300 block of N. Malden Avenue in La Grange Park, was stopped Jan. 24 for speeding over the posted limit at Forest and Ogden avenues.
Tags: reports
license
western
police
ANGP gets exclusive license to UTRC technology for conformable natural gas vehicle storage tanks
2016-02-04 16:56:18| Green Car Congress
Tags: technology
natural
license
storage
Texas police now double as debt collectors thanks to free license plate readers
2016-01-27 20:20:36| Extremetech
Police in Texas have signed deals with license plate reader companies that turn cops into debt collectors and give companies private financial data. The information gathered through these deals is now being monetized in a variety of ways in an unprecedented violation of citizen privacy.
Tags: free
double
license
texas
Merck Announces FDA Acceptance of Biologics License Application for Bezlotoxumab, an Investigational Antitoxin for Prevention of Clostridium Difficile Infection Recurrence
2016-01-27 14:30:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. FDA Grants Priority Review with Target Action Date of July 23, 2016 Marketing Authorization Application Also Filed with the European Medicines Agency KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for bezlotoxumab, an investigational antitoxin for prevention of Clostridium difficile (C. difficile) infection recurrence. The FDA granted Priority Review for bezlotoxumab, with a Prescription Drug User Fee Act (PDUFA) action date of July 23, 2016. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Robert Consalvo, 908-236-1127orInvestors:Teri Loxam, 908-740-1986Amy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: application
license
acceptance
prevention
Sites : [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] next »